Literature DB >> 32234536

Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium Cohort.

Hashem B El-Serag1, Fasiha Kanwal2, Ziding Feng3, Jorge A Marrero4, Saira Khaderi5, Amit G Singal4.   

Abstract

Entities:  

Keywords:  Alcoholic Liver Disease; Cirrhosis; HCV Infection; Hepatocellular Carcinoma; Nonalcoholic Fatty Liver Disease

Mesh：

Year:  2020        PMID： 32234536      PMCID： PMC8375364          DOI： 10.1053/j.gastro.2020.03.049

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  8 in total

1.  Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis.

Authors:  Javier Ampuero; Raluca Pais; Rocío Aller; Rocío Gallego-Durán; Javier Crespo; Carmelo García-Monzón; Jerome Boursier; Eduardo Vilar; Salvatore Petta; Ming-Hua Zheng; Desamparados Escudero; Jose Luis Calleja; Patricia Aspichueta; Moisés Diago; Jose Miguel Rosales; Joan Caballería; Judith Gómez-Camarero; Oreste Lo Iacono; Salvador Benlloch; Agustín Albillos; Juan Turnes; Jesus M Banales; Vlad Ratziu; Manuel Romero-Gómez
Journal:  Clin Gastroenterol Hepatol       Date:  2019-06-11       Impact factor: 11.382

2.  Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.

Authors:  Donna L White; Aaron P Thrift; Fasiha Kanwal; Jessica Davila; Hashem B El-Serag
Journal:  Gastroenterology       Date:  2016-11-23       Impact factor: 22.682

3.  Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents.

Authors:  Fasiha Kanwal; Jennifer Kramer; Steven M Asch; Maneerat Chayanupatkul; Yumei Cao; Hashem B El-Serag
Journal:  Gastroenterology       Date:  2017-06-19       Impact factor: 22.682

4.  Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.

Authors:  Yao-Chun Hsu; Terry Cheuk-Fung Yip; Hsiu J Ho; Vincent Wai-Sun Wong; Yen-Tsung Huang; Hashem B El-Serag; Teng-Yu Lee; Ming-Shiang Wu; Jaw-Town Lin; Grace Lai-Hung Wong; Chun-Ying Wu
Journal:  J Hepatol       Date:  2018-03-16       Impact factor: 25.083

5.  Hospitalizations for Chronic Liver Disease: Time to Intervene at Multiple Levels.

Authors:  Hashem B El-Serag
Journal:  Gastroenterology       Date:  2018-08-01       Impact factor: 22.682

6.  Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.

Authors:  Nicole E Rich; Stefany Oji; Arjmand R Mufti; Jeffrey D Browning; Neehar D Parikh; Mobolaji Odewole; Helen Mayo; Amit G Singal
Journal:  Clin Gastroenterol Hepatol       Date:  2017-09-29       Impact factor: 11.382

7.  Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study.

Authors:  Ziding Feng; Jorge A Marrero; Saira Khaderi; Amit G Singal; Fasiha Kanwal; Nicole Loo; Laura Beretta; Jing Ning; Hashem B El-Serag
Journal:  Am J Gastroenterol       Date:  2019-03       Impact factor: 12.045

8.  Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study.

Authors:  Elliot B Tapper; Neehar D Parikh
Journal:  BMJ       Date:  2018-07-18
  8 in total
  9 in total

Review 1.  Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?

Authors:  Nicole E Rich; Amit G Singal
Journal:  Hepatology       Date:  2022-01-18       Impact factor: 17.425

2.  Clinical Characteristics and Outcomes of Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in the United States.

Authors:  Mohammad A Karim; Amit G Singal; Hye Chung Kum; Yi-Te Lee; Sulki Park; Nicole E Rich; Mazen Noureddin; Ju Dong Yang
Journal:  Clin Gastroenterol Hepatol       Date:  2022-03-17       Impact factor: 13.576

3.  Risk factors for HCC in contemporary cohorts of patients with cirrhosis.

Authors:  Fasiha Kanwal; Saira Khaderi; Amit G Singal; Jorge A Marrero; Nicole Loo; Sumeet K Asrani; Christopher I Amos; Aaron P Thrift; Xiangjun Gu; Michelle Luster; Abeer Al-Sarraj; Jing Ning; Hashem B El-Serag
Journal:  Hepatology       Date:  2022-03-01       Impact factor: 17.298

4.  HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.

Authors:  Amit G Singal; Emily Zhang; Manasa Narasimman; Nicole E Rich; Akbar K Waljee; Yujin Hoshida; Ju Dong Yang; Maria Reig; Giuseppe Cabibbo; Pierre Nahon; Neehar D Parikh; Jorge A Marrero
Journal:  J Hepatol       Date:  2022-02-06       Impact factor: 30.083

Review 5.  Rational HCC screening approaches for patients with NAFLD.

Authors:  Amit G Singal; Hashem B El-Serag
Journal:  J Hepatol       Date:  2021-09-09       Impact factor: 25.083

Review 6.  Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk.

Authors:  Naoto Kubota; Naoto Fujiwara; Yujin Hoshida
Journal:  J Clin Med       Date:  2020-11-26       Impact factor: 4.241

7.  The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy.

Authors:  Ariel C Harrison; Fasiha Kanwal; Sumeet K Asrani; Aaron P Thrift; Chris I Amos; Maria L Jibaja-Weiss; Jane R Montealegre; Jessica P Hwang; Amit G Singal; Hashem B El-Serag
Journal:  Front Oncol       Date:  2022-08-19       Impact factor: 5.738

8.  Lipidomic Profiles of Plasma Exosomes Identify Candidate Biomarkers for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis.

Authors:  Jessica I Sanchez; Jingjing Jiao; Suet-Ying Kwan; Lucas Veillon; Marc O Warmoes; Lin Tan; Mobolaji Odewole; Nicole E Rich; Peng Wei; Philip L Lorenzi; Amit G Singal; Laura Beretta
Journal:  Cancer Prev Res (Phila)       Date:  2021-07-12

9.  Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis.

Authors:  Amit G Singal; Sruthi Patibandla; Joseph Obi; Hannah Fullington; Neehar D Parikh; Adam C Yopp; Jorge A Marrero
Journal:  Clin Gastroenterol Hepatol       Date:  2020-09-10       Impact factor: 13.576
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.